A Phase i dose-escalation study of the VEGFR inhibitor tivozanib hydrochloride with weekly paclitaxel in metastatic breast cancer

Erica L. Mayer, M. E. Scheulen, J. Beckman, H. Richly, A. Duarte, M. M. Cotreau, A. L. Strahs, S. Agarwal, L. Steelman, E. P. Winer, M. N. Dickler

Research output: Contribution to journal › Article › peer-review